You are on page 1of 12




Infectious Diseases Diagnostics Market Size is anticipated to grow at a 7.90% CAGR from
2016 to 2021 and it is estimated that the global market was valued at USD 14.45 billion in
2016 and is relied upon to achieve USD 21.13 billion by 2021. Infectious disease diagnostics
involves various methods to check for the presence of foreign antigen/organism with the
help of numerous diagnostic tools. Infectious disease conditions are highly widespread in
under developed regions owing to the lack of awareness for personal hygiene, minimal
health care expenditures, and absence of efficient physician services. Rising cases of
infectious diseases in developed economies is further expected to boost the market growth.
This has lead vitro diagnostic device manufacturers to invest into emerging economies.
These companies are taking efforts to develop and commercialize cost effective tools for the
infectious disease diagnosis.

Disease diagnostics are used for confirmation of a disease in form of a quick, precise test
result. Being time consuming, disease diagnostics are on a rise. The infectious disease
epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic
tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise,
creating a robust demand for infectious disease diagnostics. With a majority of physicians
adopting the evidence-based treatment method, infectious disease diagnostic kits are more
likely to gain traction over the forecast period. Several government-funded programs all
over the globe are increasingly providing free screening and tests in order to increase
awareness, accurately diagnose diseases, and minimize the chances of infection. Such
initiatives are anticipated to boost the market growth in the next few years. However,
diagnostic kits are expensive and manufacturers still have a poor distribution channel for
operating across emerging economies. These two factors are projected to be the key
challenges to rapid revenue growth of the global infectious diseases diagnostics market.

Infectious Diseases Diagnostics Market Segmentation by Product, Application, Technology

and End User. On the basis of Product, it is segmented into Instruments, Reagents, Services,
and Software. Consumables accounted for the largest share. On the basis of Application, it is
segmented into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis
(TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus
(HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola,
Typhoid, Malaria, and Dengue) included. Hospital-acquired MRSA infections and human
papillomavirus (HPV) are expected to be the fastest-growing market segments in the
forecast period. On the basis of technology, it is segmented into PCR, INAAT, DNA
Sequencing and Hybridization. Traditional methods are categorized into immunodiagnostics,
microscopy, and biochemical characterization. Microarrays and INAAT are projected to
witness the highest growth during the forecast period. This noteworthy growth can be
accredited to the specificity and an increase in the efficiency of these tests. On the basis of
End User, it is segmented into Hospital and Laboratories. Hospital laboratories and
reference labs held the largest share in this market segment.

Infectious Diseases Diagnostics Market geographical segmentation by North America,

Europe, Asia-Pacific and Middle East and Africa. North America held the largest share of the
IDD market, followed by Europe. Both regions are projected to witness single-digit growth
rates during the coming years. Be that as it may, Asia-Pacific is projected to register the
highest growth rate in the coming years, due to the high pervasiveness of infectious
diseases, and huge investment opportunities due to a growth in healthcare expenditure.

Market Segmentation:
1 Product
1.1 Introduction
1.2 Instruments & Analyzers
1.3 Consumables
1.3.1 Assays and Reagents
1.4 Services & Softwares
1.5 Y-o-Y Growth Analysis, By Product
1.6 Market Attractiveness Analysis, By Product
1.7 Market Share Analysis, By Product

2 Techniques
2.1 Introduction
2.2 Traditional Diagnostic Techniques
2.2.1 Immunodiagnostics
2.2.2 Microscopy
2.2.3 Biochemical Characterization
2.3 Molecular Diagnostics
2.3.1 PCR
2.3.2 INAAT
2.3.2 Hybridization
2.3.3 DNA Sequencing & NGS
2.3.4 Microarray
2.3.5 Others
2.4 Y-o-Y Growth Analysis, By Technique
2.5 Market Attractiveness Analysis, By Technique
2.6 Market Share Analysis, By Technique
3 Applications
3.1 Introduction
3.2 Hepatitis B
3.3 Hepatitis C
3.4 Human Immunodeficiency Virus (HIV)
3.5 Tuberculosis (TB)
3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)
3.7 Human papillomavirus (HPV)
3.8 Methicillin-resistant Staphylococcus aureus (MRSA)
3.9 Others
3.10 Y-o-Y Growth Analysis, By Application
3.11 Market Attractiveness Analysis, By Application
3.12 Market Share Analysis, By Application

4 End User
4.1 Introduction
4.2 Hospitals Laboratories
4.3 Physician office Labs
4.4 Academics
4.5 Others

The major Infectious Diseases Diagnostics Market leaders are Abbott Laboratories,
bioMrieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company,
Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A.,
Quidel Corporation, and Bio-Rad Laboratories, Inc.

1. Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

View Report at


2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

Get free sample report at

5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments & Analyzers
5.1.3 Consumables Assays and Reagents
5.1.4 Services & Softwares
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product

5.2 Technique
5.2.1 Introduction
5.2.2 Traditional Diagnostic Techniques Immunodiagnostics Microscopy Biochemical Characterization
5.2.3 Molecular Diagnostics PCR INAAT Hybridization DNA Sequencing & NGS Microarray Others
5.2.4 Y-o-Y Growth Analysis, By Technique
5.2.5 Market Attractiveness Analysis, By Technique
5.2.6 Market Share Analysis, By Technique
Request Customization at

5.3 Application
5.3.1 Introduction
5.3.2 Hepatitis B
5.3.3 Hepatitis C
5.3.4 Human Immunodeficiency Virus (HIV)
5.3.5 Tuberculosis (TB)
5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)
5.3.7 Human papillomavirus (HPV)
5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)
5.3.9 Others
5.3.10 Y-o-Y Growth Analysis, By Application
5.3.11 Market Attractiveness Analysis, By Application
5.3.12 Market Share Analysis, By Application

5.4 End User

5.4.1 Introduction
5.4.2 Hospitals Laboratories
5.4.3 Physician office Labs
5.4.4 Academics
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User

Enquire before buying at


6. Geographical Analysis
6.1 North America

6.1.1 Introduction

6.1.2 United States

6.1.3 Canada

6.2 Europe

6.2.1 Introduction

6.2.2 U.K

6.2.3 Spain

6.2.4 Germany

6.2.5 Italy

6.2.6 France

Buy this report at


6.3 Asia-Pacific

6.3.1 Introduction

6.3.2 China

6.3.3 India

6.3.4 Japan

6.4 Latin America

6.4.1 Introduction

6.4.2 Brazil

6.4.3 Argentina
6.4.4 Mexico

6.5 Middle East & Africa

6.5.1 Introduction

6.5.2 Middle-East

6.5.3 Africa

7. Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porters Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis

8.1 Abbott Laboratories

8.1.1 Overview
8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 bioMrieux SA

8.3 Hologic Inc.

8.4 Danaher Corporation

8.5 Sbecton

8.6 Dickinson and Company

8.7 Cepheid Inc.

8.8 Thermo Fisher Scientific Inc.

8.9 Roche Diagnostics

8.10 Alere Inc.

9. Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10. Market Outlook and Investment Opportunities


a) List of Tables
b) List of Figures

For more related reports from Healthcare IT segment:

A. Genomics Market:


B. Medical Tourism Market:


C. Transcatheter Aortic Valve Replacement (TAVR) Market:


D. Empty Capsules Market:



Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the major countries/regions in which this industry is blooming
and to also identify the regions that are still untapped
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global
market; which includes broadly demographic, economics, and political, among other
macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an
Industry, using Porters five forces analysis for analyzing the level of competition
and business strategy development
A comprehensive list of key market players along with their product portfolio,
current strategic interests, key financial information, legal issues, SWOT analysis and
analyst overview to study and sustain the market environment
An executive summary, abridging the entire report in such a way that decision-
making personnel can rapidly become acquainted with background information,
concise analysis and main conclusions

Market Data Forecast is a firm working in the areas of market
research and business intelligence. We have rich experience in
research across various business domains and we cater to the needs
of both individual and corporate clients. Our research services assist
clients in key business areas like business process improvement, key
decision making and developing appropriate corporate strategy. We
are truly committed to our clients and other stakeholders for
providing customized research services of the highest quality.

We always look forward to working with new clients, pushing our
boundaries and extending our reach beyond global horizons. Get in
touch with us for further queries.



Phone: +1 888-702-9626 (U.S Toll free),

+91 7680952236 (Indian Office).